Skip to main content
Figure 1 | Clinical Proteomics

Figure 1

From: Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation

Figure 1

Overview of the (A) experimental design and (B) analytical strategy of the label-free quantitative phosphoproteomic workflow. RBC membrane ghosts from healthy (AA) or sickle (SS) patients were proteolytically digested and then subjected to a TiO2 based phosphopeptide enrichment. Following LC-MS/MS analysis, all data files were subjected to AMRT alignment within Rosetta Elucidator and selected ion chromatograms were generated from each phosphopeptide precursor ion to measure abundance.

Back to article page

Clinical Proteomics

ISSN: 1559-0275